Results 121 to 130 of about 5,866 (194)

Efficacy and Safety of Dose-Dense Chemotherapy in Breast Cancer: Real Clinical Data and Literature Review. [PDF]

Curr Oncol
Yanagihara K, Yoshida M, Yamakawa T, Kato S, Tamura M, Nagata K.   +5 more
europepmc   +1 more source

The use of granulocyte colony-stimulating factors in the management of breast cancer patients. [PDF]

Front Oncol
Bałata A, Szombara E, Nowecki ZI, Pogoda K.   +3 more
europepmc   +1 more source

Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim. [PDF]

Thorac Cancer
Makiguchi T, Odagiri H, Tanaka H, Taima K, Tasaka S.   +4 more
europepmc   +1 more source

Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy. [PDF]

Oncologist
Modiano M, Chawla S, Vacirca JL, Crist K, Franklin H, Schwartzberg L.   +5 more
europepmc   +1 more source

Prolonged myopathy and musculoskeletal symptoms following filgrastim in a 43-Year-Old female stem cell donor: a case-based review. [PDF]

Rheumatol Int
Rogowska J, Kakowski R, Makowska J, Brzezińska O.   +3 more
europepmc   +1 more source

NICE DSU Technical Support Document 3: Heterogeneity: Subgroups, Meta-Regression, Bias and Bias-Adjustment [PDF]

, 2011
Ades, A E, Dias, Sofia, Sutton, Alex J, Welton, Nicky J   +3 more
core   +2 more sources

Aortitis after granulocyte-colony stimulating factor administration: A case report. [PDF]

Biomed Rep
Fujiwara S, Hara H, Fukase N, Sawada R, Takemori T, Miyamoto T, Nakamatsu Y, Kuroda R, Akisue T.   +8 more
europepmc   +1 more source

Risks of haematological malignancies in patients treated for solid tumours associated with the use of pegylated granulocyte colony-stimulating factors: A single centre study since 2005. [PDF]

Oncol Lett
Vokurka S, Mastný L, Kliment V, Kulhánková J, Dreslerová J, Šamanová T, Fínek J.   +6 more
europepmc   +1 more source

Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation. [PDF]

Clin Exp Med
Zhou Y, Qian H, Zheng J, Lu Y, Ye P.
europepmc   +1 more source

Sacituzumab-induced severe or febrile neutropenia and G-CSF utilization and cost for advanced HER2-negative breast cancer: a single-center retrospective analysis. [PDF]

Breast Cancer Res Treat
Tam G, Waddell D, Freeman JQ, Chen N, Yang H.   +4 more
europepmc   +1 more source